Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amino acid peritoneal dialysis solution in malnourished PD patients
ChiCTR2500107912Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2025
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amino acid peritoneal dialysis solution in end-stage kidney disease (ESKD), sponsored by West China Hospital of Sichuan University. Primary endpoint: serum albumin. Started Aug 2025; status: completed.
02
Drugs
amino acid peritoneal dialysis solution
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2500107912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107912.